Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gannex Pharma Co., Ltd.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 and ≤ 80 years old at screening.
Presence of ≥ 7.5% steatosis on screening MRI-PDFF read centrally by a radiologist and performed either during the screening period or within 6 months prior to the first visit.
HbA1c ≤ 9.5%.
Normal or minimally abnormal renal function as defined by estimated glomerular filtration rate (eGFR) ≥ 50 mL/min/1.73 m\^2
You may not be if
Presence or history of cirrhosis or evidence of decompensated liver disease (e.g., ascites, variceal bleeding) or hepatocellular carcinoma.
History or presence of other concomitant liver disease as assessed by the investigator or determined by laboratory findings.
Uncontrolled Type 2 diabetes mellitus (T2DM) defined as HbA1c of \> 9.5% within 60 days prior to enrollment.
Change in anti-diabetic therapy within 6 months prior to qualifying liver biopsy.
